Option Care Health (NASDAQ:OPCH) Lifted to “Buy” at Zacks Investment Research

Option Care Health (NASDAQ:OPCH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Saturday, Zacks.com reports. The brokerage currently has a $28.00 price target on the stock. Zacks Investment Research‘s price target points to a potential upside of 15.08% from the company’s current price.

According to Zacks, “Option Care Health Inc provides infusion and home care management solutions. The Company offers products, services and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders and heart failures. Option Care Health Inc., formerly known as BioScrip Inc., is based in Denver, United States. “

Other equities analysts have also recently issued research reports about the stock. TheStreet upgraded shares of Option Care Health from a “c+” rating to a “b” rating in a research note on Thursday, December 9th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Option Care Health from $23.50 to $32.00 and gave the stock a “buy” rating in a research note on Friday, November 5th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $28.14.

Shares of OPCH stock opened at $24.33 on Friday. Option Care Health has a 12 month low of $16.02 and a 12 month high of $28.86. The stock has a market cap of $4.38 billion, a PE ratio of 52.89 and a beta of 1.35. The company has a current ratio of 1.67, a quick ratio of 1.28 and a debt-to-equity ratio of 1.02. The company’s fifty day moving average price is $26.48 and its 200-day moving average price is $24.60.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Thursday, November 4th. The company reported $0.20 EPS for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.01. The firm had revenue of $891.94 million for the quarter, compared to analysts’ expectations of $886.47 million. Option Care Health had a net margin of 2.48% and a return on equity of 7.86%. The company’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.01 EPS. On average, sell-side analysts forecast that Option Care Health will post 0.59 earnings per share for the current fiscal year.

In other Option Care Health news, COO Harriet Booker sold 6,000 shares of the business’s stock in a transaction dated Monday, December 6th. The stock was sold at an average price of $24.81, for a total value of $148,860.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In the last three months, insiders sold 18,000 shares of company stock valued at $474,180. 47.00% of the stock is owned by insiders.

Large investors have recently modified their holdings of the business. Nisa Investment Advisors LLC purchased a new position in Option Care Health in the 2nd quarter worth about $26,000. US Bancorp DE raised its position in Option Care Health by 16.4% in the 3rd quarter. US Bancorp DE now owns 2,843 shares of the company’s stock worth $69,000 after buying an additional 400 shares during the last quarter. FORA Capital LLC purchased a new position in Option Care Health in the 2nd quarter worth about $71,000. Advisor Group Holdings Inc. raised its position in Option Care Health by 110.0% in the 2nd quarter. Advisor Group Holdings Inc. now owns 3,561 shares of the company’s stock worth $78,000 after buying an additional 1,865 shares during the last quarter. Finally, Dark Forest Capital Management LP purchased a new position in Option Care Health in the 2nd quarter worth about $89,000. 95.99% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc engages in the provision of home and alternate site infusion services. The firm involves in the clinical management of infusion therapy, nursing support, and care coordination. It also offers anti-infective, nutrition support, heart failure, chronic inflammatory disorders, immunoglobulin, bleeding disorders, women’s health, neurological disorders, and specialized therapies.

Featured Article: Understanding Price to Earnings Ratio (PE)

Get a free copy of the Zacks research report on Option Care Health (OPCH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.